- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
Patent holdings for IPC class A61P 1/00
Total number of patents in this class: 7383
10-year publication summary
|
239
|
420
|
481
|
570
|
648
|
677
|
723
|
519
|
535
|
416
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 10044 |
71 |
| Takeda Pharmaceutical Company Limited | 2700 |
48 |
| DSM IP Assets B.V. | 5387 |
45 |
| The Regents of the University of California | 20902 |
41 |
| N.V. Nutricia | 1100 |
37 |
| Nestec S.A. | 2540 |
36 |
| Cedars-Sinai Medical Center | 1210 |
36 |
| Novartis AG | 10169 |
34 |
| The Johns Hopkins University | 5938 |
31 |
| Glycom A/S | 246 |
30 |
| Janssen Pharmaceutica N.V. | 3147 |
29 |
| Eli Lilly and Company | 4118 |
29 |
| Raqualia Pharma Inc. | 122 |
27 |
| Pfizer Inc. | 3418 |
26 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3324 |
26 |
| F. Hoffmann-La Roche AG | 7798 |
25 |
| Centre National de La Recherche Scientifique | 11111 |
25 |
| Janssen Biotech, Inc. | 1794 |
25 |
| Osaka University | 3257 |
24 |
| Taisho Pharmaceutical Co., Ltd. | 846 |
23 |
| Other owners | 6715 |